Structure of Givinostat HCl monohydrate
CAS No.: 732302-99-7
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
ITF2357 HCl H2O is a potent HDAC inhibitor for Maize HD2, HD1-B and HD1-A with IC50 of 10 nM, 7.5 nM and 16 nM, respectively.
Synonyms: ITF2357; Givinostat; ITF-2357 hydrochloride monohydrate
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 732302-99-7 |
Formula : | C24H30ClN3O5 |
M.W : | 475.97 |
SMILES Code : | O=C(OCC1=CC=C2C=C(CN(CC)CC)C=CC2=C1)NC3=CC=C(C(NO)=O)C=C3.[H]Cl.[H]O[H] |
Synonyms : |
ITF2357; Givinostat; ITF-2357 hydrochloride monohydrate
|
MDL No. : | MFCD28502062 |
InChI Key : | FKGKZBBDJSKCIS-UHFFFAOYSA-N |
Pubchem ID : | 9804991 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
Target |
|
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
Primary glial cells | 1 µM and 10 µM | 6 h | The study showed a positive effect of Givinostat that involved a substantial decrease in IL-1β expression potentiated by LPS. | PMC9368553 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
C57BL/6J mice | MCD diet model | Intraperitoneal injection | 10 mg/kg | Daily for 8 weeks | To assess the therapeutic efficacy of givinostat in alleviating liver inflammation and fibrosis induced by MCD diet. | PMC8975805 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT01557452 | Juvenile Idiopathic Arthritis | TERMINATED | 2014-01-27 | 1st Faculty of Medicine and Ge... More >>neral Faculty Hospital, Praha, 12109, Czechia Less << | |
NCT05860114 | Drug Drug Interaction | PHASE1 | COMPLETED | 2022-05-24 | Hospital da Prelada, 3rd Floor... More >> & East Wing 4th Floor Rua Sarmento de Beires, Porto, 153, Portugal Less << |
NCT00442182 | Autoinflammatory Syndromes|HID... More >>S|TRAPS|Schnitzler's Syndrome Less << | PHASE2 | UNKNOWN | - | Radboud University Medical Cen... More >>tre Nijmegen, Nijmegen, 6500 HB, Netherlands Less << |
NCT06736223 | Hepatic Impairment | PHASE1 | NOT_YET_RECRUITING | 2025-06-25 | MC COMAC Medical Ltd, Sofia, 1... More >>606, Bulgaria|MC COMAC Medical Ltd, Sofia, 1612, Bulgaria|Biotrial, Rennes, 35042, France Less << |
NCT03373968 | Duchenne Muscular Dystrophy | PHASE2|PHASE3 | ENROLLING_BY_INVITATION | 2025-12-25 | University of California - Dav... More >>is Medical Center - Devis Physical Medicine & Rehabilitation, Sacramento, California, 95817, United States|Rady Children's Hospital center - UCSD Department of Neuroscience, San Diego, California, 92123, United States|Connecticut Children's Medical Center, Neurology Division, Hartford, Connecticut, 06106, United States|Child Health Research Institute, Gainesville, Florida, 32610, United States|MD Rare Disease Research, LLC, Atlanta, Georgia, 30318, United States|University of Iowa Children's Hospital, Iowa City, Iowa, 52242, United States|Washington University School of Medicine in St Louis Department of Neurology 660 S.Euclid Avenue, Campus Box 8111, Saint Louis, Missouri, 63110, United States|Shriners Hospitals for Children, Portland, Oregon, 97239, United States|The Children's Hospital of Philadelphia Colket Translational Research Building, Philadelphia, Pennsylvania, 19104, United States|Virginia Commonwealth University Childrens Hospital of Richmond at, Richmond, Virginia, 23298, United States|University Hospitals Leuven, Neuromuscular Reference Centre, Child Neurology, Leuven, 03000, Belgium|Hospital de La Citadelle, Centre de Référence des Maladies Neuromuscolaires (CRMN), Liège, 04000, Belgium|Kinsmen Research Centre - Alberta Children's Hospital, Calgary, Alberta, T3B 6A8, Canada|The University of British Columbia, Children's and Womens Health Centre of BC Branch, Vancouver, British Columbia, V6H 3V4, Canada|Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, M4G1R8, Canada|CHU de Nantes - Hotel-Dieu - Hopital Nord Laennec, rez-de-chausse haut ail Ouest, Nantes, 44093, France|H?pital Armand Trousseau I-Motion - Plateforme d'essais cliniques pédiatriques Batiment Lemariey - Porte 20 * 2ème étage 26 Avenue du Dr Arnold Nette, Paris, 760, France|Universit?tsklinikum Essen - Kinder-und Jugendmedizin Neuropadiatrie, Essen, D-45147, Germany|Klinik- und Poliklinik fur Kinder- und Jugendmedizin, Universitatsklinikum HamburgEppendorf, Martinistr. 52, Hamburg, 20246, Germany|Klinikum der Universitat Munchen, Campus Innenstadt, Lindwurmstr. 4, München, 80337, Germany|Institute of Neurology - Schneider Children's Medical Center of Israel Kaplan, 14, Petach-Tikva, 4920235, Israel|U.O.S.D. Centro Traslazionale di Miologia e Patologie Neurodegenerative, Building 16 - ground floor IRCCS Istituto Giannina Gaslini,, Genova, 16147, Italy|A.O.U. Policlinico G. Martino, U.O.C. Neurologia e Malattie Neuromuscolari, Messina, 98125, Italy|IRCCS Istituto Neurologico Carlo Besta, Milano, 20133, Italy|Centro Clinico NeMO Fondazione Serena ONLUS Area SUD, Milano, 20162, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, UOS di Neurologia Pediatrica, Milan, 20122, Italy|Ospedale Pediatrico Bambino Gesù, Malattie Neuromuscolari e Neurodegenerative, Roma, 00146, Italy|Fondazione Policlinico Universitario "A.Gemelli", UOC Neuropsichiatria Infantile, Roma, 00168, Italy|Leiden University Medical Center LUMC, Albinusdreef 2, Leiden, 2300, Netherlands|Radboud University Medical Centre, Nijmegen, 6500, Netherlands|Clinic of Neurology and Psychiatry for Children and Youth - Neurology Department Dr. Subotic 6a,, Belgrade, 11000, Serbia|Neuromuscular Pathology Unit - Hospital Sant Joan de Déu, Esplugues De Llobregat, Barcellona, 08950, Spain|Hospital Materno-Infantil, Barcelona, 08035, Spain|Hospital Universitario Virgen del Rocio, Sevilla, 41013, Spain|Hospital Universitari i Politècnic La Fe - Servicio Neurologia, Valencia, Spain|Alder Hey Children's Hospital NHS Trust, Liverpool, UK, L12 2AP, United Kingdom|The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, Gobowen, SY10 7AG, United Kingdom|UCL Great Ormond Street Institute of Child Health, Dubowitz Neuromuscular Centre and MRC Centre for NMD, London, , WC1N 1EH, United Kingdom|The John Walton Muscular Dystrophy Research Centre, Newcastle Upon Tyne, NE1 3BZ, United Kingdom Less << |
NCT00570661 | Active Systemic|Onset Juvenile... More >> Idiopathic Arthritis Less << | PHASE2 | COMPLETED | 2013-06-10 | Clinica Institute Fundeni.Pedi... More >>atric Clinic 258 Sos. Fundeni,, Bucharest, 022328, Romania|Clinical Emergency Children Hospital "M.S. Curie" Paediatric Clinic no. I 20 Ctin. Brancoveanu Bvd., 041451 Bucharest 4th district, Bucharest, 041451, Romania|University Clinical Centre NisClinic of Paediatrics Department for Rheumatology Bul Dr Zoran Djindjica, Ni?, Nis, 18000, Serbia|Mother and Child Health Institute "Dr. Vukan Cupic" Clinic of Paediatrics Radoja Dakica, Belgrade, Novi Belgrade, 6-811070, Serbia|Institute of Rheumatology Belgrade Resavska, Belgrade, 6911000, Serbia Less << |
NCT01901432 | Polycythemia Vera | PHASE1|PHASE2 | COMPLETED | 2017-09-25 | CHU Amiens - H?pital Sud, Amie... More >>ns Cedex 1, 80054, France|H?pital Morvan - CHRU de Brest, Brest Cedex, 29609, France|Hopital Saint Vincent de Paul - GHICL Lille, Lille cedex, 59020, France|H?pital Saint-Louis (AP-HP), Centre Investigations Cliniques, Paris Cedex 10, 75475, France|Charite Research Organisation GmbH, Berlin, 10117, Germany|Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden, 01307, Germany|Universitaetsklinikum Freiburg, Freiburg, 79106, Germany|Universitaetsklinikum Koeln, Koeln, 50937, Germany|Azienda ospedaliero universitaria Consorziale Policlinico di Bari, Bari, BA, 70124, Italy|Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, BG, 24127, Italy|Azienda Ospedaliero-Universitaria Careggi, Florence, Florence, FI, 50134, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, PV, 27100, Italy|Istituto Tumori Giovanni Paolo II - IRCCS Ospedale Oncologico di Bari, Bari, 70124, Italy|Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano, Italy|Università degli Studi di Napoli Federico II, Facoltà di Medicina e Chirurgia, Napoli, 80131, Italy|Ospedale Civile dello Spirito Santo, Pescara, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, 56126, Italy|Azienda Ospedaliera "Bianchi-Melacrino-Morelli", Reggio Calabria, 89125, Italy|Università Campus Bio-Medico di Roma, Rome, Italy|Ospedale San Bortolo di Vicenza, Vicenza, 36100, Italy|SP ZOZ Zespol Szpitali Miejskich w Chorzowie, Chorzow, 41-500, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, 80-952, Poland|Belfast City Hospital, Belfast, BT9 7BL, United Kingdom|Royal London Hospital, London, E1 1BB, United Kingdom|Royal Cornwall Hospital, Truro, TR1 3LJ, United Kingdom Less << |
NCT00792467 | Hodgkin's Lymphoma | PHASE1|PHASE2 | COMPLETED | 2025-09-10 | Istituto Nazionale per la Cura... More >> e lo Studio dei Tumori, Milano, 20133, Italy Less << |
NCT01761292 | Duchenne Muscular Dystrophy (D... More >>MD) Less << | PHASE1|PHASE2 | COMPLETED | 2025-11-17 | Azienda Ospedaliera Universita... More >>ria Policlinico G. Martino, Messina, 98125, Italy|IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, 20122, Italy|Policlinico Agostino Gemelli, Roma, 00168, Italy|Ospedale Pediatrico Bambino Gesù, Rome, 00165, Italy Less << |
NCT01261624 | Polyarticular Course Juvenile ... More >>Idiopathic Arthritis Less << | PHASE2 | TERMINATED | 2025-03-13 | Universitair Ziekenhuis Gent, ... More >>Gent, 9000, Belgium|1st Faculty of Medicine and General Faculty Hospital, Praha 2, Praha, 12109, Czech Republic|Ospedale Meyer, Firenze, FI, 50139, Italy|Policlinico G. Martino, Messina, ME, 98125, Italy|Istituto Gaetano Pini, Milano, MI, 20122, Italy|Azienda Ospedaliera-Università di Padova, Padova, PD, 35128, Italy|Institutul pentru Ocrotirea Mamei si Copilului "Alfred Rusescu", Bucarest, 020395, Romania|Spitalul Clinic de Urgenta pentru Copii "M.S. Curie", Bucarest, 041451, Romania|Mother and Child Health Institute "Dr Vukan Cupic", Novi Beograd, Belgrade, 11070, Serbia|Institute of Rheumatology Belgrade, Belgrade, 11000, Serbia|University Clinical Center Nis, Nis, 18000, Serbia|Children's Hospital - University Medical Centre Ljubljana, Ljubljana, SI-1000, Slovenia|Hospital Ramón y Cajal, Madrid, 28034, Spain Less << |
NCT00792831 | Chronic Lymphocytic Leukemia | PHASE2 | TERMINATED | 2025-04-09 | Department of Internal Medicin... More >>e and Public Health, University of Perugia, Perugia, 06074, Italy Less << |
NCT00606307 | Myeloproliferative Diseases | PHASE2 | COMPLETED | 2025-12-08 | Ospedali riuniti, Bergamo, 241... More >>58, Italy|IRCCS - Pol. San Matteo, Pavia, 27100, Italy Less << |
NCT00792506 | Multiple Myeloma | PHASE2 | TERMINATED | 2025-07-10 | Presidio Ospedaliero R. Binagh... More >>i, Cagliari, 09127, Italy Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.10mL 0.42mL 0.21mL |
10.50mL 2.10mL 1.05mL |
21.01mL 4.20mL 2.10mL |
Tags: Givinostat hydrochloride | ITF-2357 hydrochloride | HDAC | Histone deacetylases | HDAC1 inhibitor | HDAC3 inhibitor | 732302-99-7
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL